Skip to content
My WebMD Sign In, Sign Up
emtricitabine-rilpivirine-tenofovir

Interactions

Atazanavir/Selected QT Prolonging Agents

This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.

Medical warning:

Moderate. These medicines may cause some risk when taken together. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.

How the interaction occurs:

Both of your medicines may affect your heart's rhythm.

What might happen:

Taking two medicines that can affect your heart rhythm may increase your risk of an irregular heartbeat, which may be life-threatening.

What you should do about this interaction:

Let your healthcare professionals (e.g doctor or pharmacist) know that you are taking these medications together. Let your doctor know right away if you notice an irregular heartbeat or have dizziness or fainting episodes. Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.

References:

1.Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010 Mar 2;55(9):934-47.

2.Saphris (asenapine) US prescribing information. Schering Corporation October, 2011.

3.Cipro (ciprofloxacin hydrochloride) US prescribing information. Bayer Corporation August, 2013.

4.Celexa (citalopram hydrobromide) US prescribing information. Forest Laboratories Inc. December, 2012.

5.Clozaril (clozapine tablets) US prescribing information. Novartis Pharmaceuticals Corporation March, 2013.

6.Ciproxin (ciprofloxacin hydrochloride) UK summary of product characteristics. Bayer plc April 13, 2010.

7.Xalkori (crizotinib) US prescribing information. Pfizer Inc. November, 2013.

8.Mathivanan M. Dear Canadian Healthcare Professional: Subject: Association of domperidone maleate with serious ventricular arrhythmias and sudden cardiac death. Teva Canada Limited March 2, 2012.

9.Halaven (eribulin mesylate) US prescribing information. Eisai, Inc. August, 2013.

10.Potiga (ezogabine) US Prescribing Information. Valeant Pharmaceuticals September, 2013.

11.Foradil Aerolizer (formoterol fumarate) US prescribing information. Schering Corporation September, 2012.

12.Symbicort Turbuhaler (budesonide-eformoterol fumarate dihydrate) Australian prescribing information. AstraZeneca Pty Ltd April 30, 2004.

13.Ablavar (gadofosveset trisodium) US prescribing information. Lantheus Medical Imaging, Inc. August, 2013.

14.Primovist (gadoxetate disodium) Australian prescribing information. Schering-Plough Corporation November 1, 2005.

15.Primovist (gadoxetic acid) UK summary of product characteristics. Bayer plc May 1, 2008.

16.Procoralan (ivabradine hydrochloride) summary of product characteristics. Servier December, 2005.

17.Serentil (mesoridazine besylate) US prescribing information. Novartis Pharmaceuticals Corporation August, 2000.

18.Kon P. Dear UK Healthcare Professional: Direct Healthcare Professional Communication on ondansetron (Zofran and generics) and dose-dependent QT interval prolongation - new dose restriction for intravenous (IV) use. GlaxoSmithKline UK Ltd August 5, 2012.

19.Zofran (ondansetron) US prescribing information. GlaxoSmithKline December, 2013.

20.USFood and Drug Administration. FDA Drug Safety Communication: Abnormal heart rhythms may be associated with use of Zofran (ondansetron). available at: http://www.fda.gov/Drugs/DrugSafety/ucm271913.htm September 15, 2011.

21.Invega (paliperidone) US prescribing information. Janssen Pharmaceuticals, Inc. April, 2011.

22.Invega Sustenna (paliperidone palmitate) US prescribing information. Janssen Pharmaceuticals, Inc. August, 2012.

23.Signifor (pasireotide diasparate) US prescribing information. Novartis Pharmaceuticals Corporation December, 2012.

24.Qualaquin (quinine sulfate) US prescribing information. AR Scientific, Inc. April, 2013.

25.Edurant (rilpivirine) US prescribing information. Tibotec Pharmaceuticals June, 2013.

26.Invirase (saquinavir mesylate) US prescribing information. Roche Laboratories, Inc. February, 2012.

27.Nexavar (sorafenib) US prescribing information. Bayer Pharmaceuticals Corporation November, 2013.

28.Vibativ (telavancin) US prescribing information. Astellas Pharma US, Inc. September, 2009.

29.Xenazine (tetrabenazine) US prescribing information. Ovation Pharmaceuticals, Inc. September, 2008.

30.Caprelsa (vandetanib) US prescribing information. AstraZeneca Pharmaceuticals LP July, 2013.

31.Zelboraf (vemurafenib) US Prescribing Information. Hoffman-La Roche March, 2014.

32.Javlor (vinflunine ditartrate) UK Summary of Product Characteristics. Pierre Fabre Limited September 21, 2009.

33.Clopixol (zuclopenthixol acetate) UK summary of product characteristics. Lundbeck House October 24, 2008.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, expect as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.

More about Drugs and Medications

Newsletters

Subscribe to free WebMD newsletters.

  • WebMD Daily

    WebMD Daily

    Subscribe to the WebMD Daily, and you'll get today's top health news and trending topics, and the latest and best information from WebMD.

  • Men's Health

    Men's Health

    Subscribe to the Men's Health newsletter for the latest on disease prevention, fitness, sex, nutrition, and more from WebMD.

  • Women's Health

    Women's Health

    Subscribe to the Women's Health newsletter for the latest on disease prevention, fitness, sex, diet, anti-aging, and more from WebMD.

By clicking Submit, I agree to the WebMD Terms & Conditions & Privacy Policy

URAC: Accredited Health Web Site HONcode Seal AdChoices